Clinical Trials for CBCC Global Research

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: CBCC Global Research

Clinical Trials (6)

NCT07117669
Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants
PHASE1/PHASE2Not yet recruiting
68 participants
Started: Aug 31, 2025 · Completed: Nov 30, 2028
1 condition2 sponsors1 location
NCT07146217
Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection
PHASE2Not yet recruiting
30 participants
Started: Aug 31, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors3 locations
NCT06234098
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
PHASE1/PHASE2Recruiting
85 participants
Started: Feb 13, 2024 · Completed: Jan 31, 2027
1 condition2 sponsors7 locations
NCT06132035
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
PHASE1Recruiting
45 participants
Started: Dec 22, 2023 · Completed: Aug 31, 2025
1 condition2 sponsors7 locations
NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
PHASE3Recruiting
168 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2022
2 conditions2 sponsors9 locations
NCT05322070
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
PHASE4Active, not recruiting
125 participants
Started: Jun 6, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors23 locations